文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

美国十年来肺炎球菌疫苗接种后肺炎住院情况。

U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.

机构信息

Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37212, USA.

出版信息

N Engl J Med. 2013 Jul 11;369(2):155-63. doi: 10.1056/NEJMoa1209165.


DOI:10.1056/NEJMoa1209165
PMID:23841730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4877190/
Abstract

BACKGROUND: The introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into the U.S. childhood immunization schedule in 2000 has substantially reduced the incidence of vaccine-serotype invasive pneumococcal disease in young children and in unvaccinated older children and adults. By 2004, hospitalizations associated with pneumonia from any cause had also declined markedly among young children. Because of concerns about increases in disease caused by nonvaccine serotypes, we wanted to determine whether the reduction in pneumonia-related hospitalizations among young children had been sustained through 2009 and whether such hospitalizations in older age groups had also declined. METHODS: We estimated annual rates of hospitalization for pneumonia from any cause using the Nationwide Inpatient Sample database. The reason for hospitalization was classified as pneumonia if pneumonia was the first listed diagnosis or if it was listed after a first diagnosis of sepsis, meningitis, or empyema. Average annual rates of pneumonia-related hospitalizations from 1997 through 1999 (before the introduction of PCV7) and from 2007 through 2009 (well after its introduction) were used to estimate annual declines in hospitalizations due to pneumonia. RESULTS: The annual rate of hospitalization for pneumonia among children younger than 2 years of age declined by 551.1 per 100,000 children (95% confidence interval [CI], 445.1 to 657.1), which translates to 47,000 fewer hospitalizations annually than expected on the basis of the rates before PCV7 was introduced. The rate for adults 85 years of age or older declined by 1300.8 per 100,000 (95% CI, 984.0 to 1617.6), which translates to 73,000 fewer hospitalizations annually. For the three age groups of 18 to 39 years, 65 to 74 years, and 75 to 84 years, the annual rate of hospitalization for pneumonia declined by 8.4 per 100,000 (95% CI, 0.6 to 16.2), 85.3 per 100,000 (95% CI, 7.0 to 163.6), and 359.8 per 100,000 (95% CI, 199.6 to 520.0), respectively. Overall, we estimated an age-adjusted annual reduction of 54.8 per 100,000 (95% CI, 41.0 to 68.5), or 168,000 fewer hospitalizations for pneumonia annually. CONCLUSIONS: Declines in hospitalizations for childhood pneumonia were sustained during the decade after the introduction of PCV7. Substantial reductions in hospitalizations for pneumonia among adults were also observed. (Funded by the Centers for Disease Control and Prevention.).

摘要

背景:2000 年,7 价肺炎球菌结合疫苗(PCV7)被引入美国儿童免疫计划,这大大降低了小儿疫苗血清型侵袭性肺炎球菌病的发病率,以及未接种疫苗的大龄儿童和成年人的发病率。到 2004 年,因任何原因导致的肺炎住院率也明显下降。由于担心非疫苗血清型疾病的增加,我们想确定儿童肺炎相关住院率是否持续下降到 2009 年,以及大龄儿童的此类住院率是否也有所下降。

方法:我们使用全国住院患者样本数据库估计因任何原因导致的肺炎住院的年发病率。如果肺炎是第一个列出的诊断,或者它是在败血症、脑膜炎或脓胸的首次诊断后列出的,则将住院的原因归类为肺炎。2007 年至 2009 年(PCV7 推出后)的平均年度肺炎相关住院率用于估计因肺炎导致的住院率的年度下降。

结果:2 岁以下儿童肺炎的年住院率下降了 551.1/10 万儿童(95%置信区间[CI]:445.1-657.1),这意味着每年比 PCV7 推出前的预期住院人数减少了 4.7 万。85 岁及以上成年人的肺炎年住院率下降了 1300.8/10 万(95%CI:984.0-1617.6),这意味着每年减少了 7.3 万例住院。对于 18-39 岁、65-74 岁和 75-84 岁三个年龄组,肺炎的年住院率分别下降了 8.4/10 万(95%CI:0.6-16.2)、85.3/10 万(95%CI:7.0-163.6)和 359.8/10 万(95%CI:199.6-520.0)。总的来说,我们估计年龄调整后的年发病率下降了 54.8/10 万(95%CI:41.0-68.5),即每年因肺炎住院的人数减少了 16.8 万。

结论:PCV7 推出后的十年间,儿童肺炎住院率下降趋势持续。成年人因肺炎住院率也大幅下降。(由疾病控制和预防中心资助)。

相似文献

[1]
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.

N Engl J Med. 2013-7-11

[2]
Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine.

Bull World Health Organ. 2012-12-11

[3]
Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era.

Vaccine. 2016-12-7

[4]
Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996-2011.

Vaccine. 2016-1-20

[5]
Pneumonia in Elderly Australians: Reduction in Presumptive Pneumococcal Hospitalizations but No Change in All-Cause Pneumonia Hospitalizations Following 7-Valent Pneumococcal Conjugate Vaccination.

Clin Infect Dis. 2015-6-11

[6]
Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.

MMWR Morb Mortal Wkly Rep. 2009-1-16

[7]
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Lancet. 2007-4-7

[8]
Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.

Clin Infect Dis. 2018-2-1

[9]
Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.

mBio. 2011-1-25

[10]
Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.

Pediatrics. 2009-11-30

引用本文的文献

[1]
Amoxicillin vs. ceftriaxone to treat pneumonia caused by amoxicillin-non-susceptible .

Antimicrob Agents Chemother. 2025-9-3

[2]
Integrating DNA and RNA sequencing for enhanced pathogen detection in respiratory infections.

J Transl Med. 2025-3-14

[3]
Effect of the Ten-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease and Pneumonia in Infants Younger Than Ten Weeks of Age in Southern Mozambique: A Population-based Prospective Surveillance Study.

Pediatr Infect Dis J. 2025-2-1

[4]
Vaccination against COVID-19 among healthcare workers as a cocoon strategy for people living with HIV.

J Virus Erad. 2024-6-10

[5]
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneumococcal colonization density in young Peruvian children.

Int J Infect Dis. 2023-9

[6]
Advances in immune response to pulmonary infection: Nonspecificity, specificity and memory.

Chronic Dis Transl Med. 2023-5-8

[7]
Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq.

Int J Gen Med. 2023-5-29

[8]
Febrile Children with Pneumonia Have Higher Nasopharyngeal Bacterial Load Than Other Children with Fever.

Pathogens. 2023-3-27

[9]
Using LASSO Regression to Estimate the Population-Level Impact of Pneumococcal Conjugate Vaccines.

Am J Epidemiol. 2023-7-7

[10]
Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia.

ERJ Open Res. 2023-3-13

本文引用的文献

[1]
Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children.

Clin Infect Dis. 2012-11-15

[2]
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR Morb Mortal Wkly Rep. 2012-10-12

[3]
Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults?

Clin Infect Dis. 2012-7

[4]
Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009.

JAMA. 2012-4-4

[5]
Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia.

Thorax. 2012-2-28

[6]
Prevention of pneumococcal infection with vaccines: an evolving story.

JAMA. 2012-2-22

[7]
Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine.

Pediatr Infect Dis J. 2012-3

[8]
Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States.

Clin Infect Dis. 2011-7-15

[9]
Serotype replacement in disease after pneumococcal vaccination.

Lancet. 2011-4-12

[10]
Diagnostic tests for agents of community-acquired pneumonia.

Clin Infect Dis. 2011-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索